Employers need to have a wider horizon than drug costs alone when considering the implementation of health care intervention programs. [electronic resource]
Producer: 20070103Description: 581-2; author reply 582-3 p. digitalISSN:- 1083-4087
- Canada
- Drug Costs
- Drug Utilization Review
- Dyspepsia -- drug therapy
- Employer Health Costs
- Enzyme Inhibitors -- economics
- Gastroesophageal Reflux -- drug therapy
- Health Benefit Plans, Employee -- standards
- Humans
- Insurance, Pharmaceutical Services -- standards
- Managed Care Programs -- economics
- Prescription Fees
- Proton Pump Inhibitors
- Quality of Health Care
- Therapeutic Equivalency
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.